Market Overview:
The global non-therapeutic antibiotics for food animals market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for meat and poultry products, rising awareness about animal health and hygiene, and growing concerns about food safety. Based on type, the global non-therapeutic antibiotics for food animals market is segmented into oxytetracyclines, tylosin, ampicillin and amoxycillin, gentamicin sulfaquinoxaline,, salinomycin,, bacitracin,, and others. The oxytetracyclines segment is projected to lead the market during the forecast period owing to its high efficiency in controlling various diseases in livestock. Based on application, cattle feed accounted for the largest share of the global non-therapeutic antibiotics for food animals market in 2017. This can be attributed to factors such as rising demand for beef products across the globe and increasing awareness about animal health among farmers.
Product Definition:
Non-therapeutic antibiotics are used in animal agriculture to improve feed efficiency and weight gain. The use of non-therapeutic antibiotics is important for food animals because it helps to prevent diseases, which can lead to significant economic losses.
Oxytetracyclines:
Oxytetracyclines are a group of antibiotics used in animals for non-therapeutic purposes. They are mainly administered to animals for the prevention and treatment of diseases caused by susceptible bacteria, such as food poisoning, cholera, dysentery and infections due to wound or bone site. Oxytetracycline is also used in poultry products to prevent disease transmission among birds.
Tylosin:
Tylosin is a chemical compound and an antibiotic used in the food-producing animals. It is also known as 4-hydroxytammin and has the formula (CH3)2NHC6H4. Tylosin occurs naturally in certain bacteria, such as Thermus thermophilus, but its production can be increased by using biotechnology techniques.
Application Insights:
Cattle feed was the largest application segment in the global non-therapeutic antibiotics for food animals market, accounting for over 40% of total revenue in 2017. The product is widely used to promote weight gain and improve animal performance. Cattle are susceptible to infections due to crowded conditions and exposure to other animals, which results in high usage of antibiotics as a growth promoter among others.
The poultry industry is one of the fastest growing industries globally with an estimated CAGR of XX% from 2018 to 2030 owing to increasing consumption of poultry products including meat, eggs and feathers among others. The use of these drugs has been found harmful not only for humans but also for birds since they can absorb antibiotic through their skin or by consuming it in contaminated food sources. This trend has led companies such as Perdue Farms Inc., Carlsbad Feed & Milling Co., LLC., etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to factors such as high animal feed production and consumption, increasing prevalence of diseases in animals, and rising awareness among farmers about using non-therapeutic antibiotics. Asia Pacific is expected to be the fastest-growing regional market from 2018 to 2030 due to factors such as improving economic conditions and rapid urbanization leading to an increase in disposable income for food products that will drive demand for meat products which will subsequently boost growth over the forecast period.
Growth Factors:
- Increasing demand for meat and poultry products: The global demand for meat and poultry is increasing due to the growing population and rising income levels. This is driving the growth of the non-therapeutic antibiotics market for food animals as they are used to improve the productivity of livestock.
- Growing awareness about animal welfare: There is a growing awareness among consumers about animal welfare issues, which is leading to an increase in demand for antibiotic-free meat products. This is benefiting the non-therapeutic antibiotics market for food animals as these products do not contain any antibiotics.
- Stringent regulations on use of antibiotics in livestock: Governments across the world are imposing stringent regulations on the use of antibiotics in livestock, which is restraining their growth prospects in this market segment. However, this could also lead to an increase in demand for antibiotic-free meat products, thereby providing opportunities for players operating in this market segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Therapeutic Antibiotics for Food Animals Market Research Report
By Type
Oxytetracyclines, Tylosin, Ampicillin and Amoxycillin, Gentamicin, Sulfaquinoxaline, Salinomycin, Bacitracin, Others
By Application
Cattle Feed, Poultry Feed, Swine Feed, Aqua Feed, Others
By Companies
AG Zoetis, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Bayer AG, AG Sanofi, Ceva Sante Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Non-Therapeutic Antibiotics for Food Animals Market Report Segments:
The global Non-Therapeutic Antibiotics for Food Animals market is segmented on the basis of:
Types
Oxytetracyclines, Tylosin, Ampicillin and Amoxycillin, Gentamicin, Sulfaquinoxaline, Salinomycin, Bacitracin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cattle Feed, Poultry Feed, Swine Feed, Aqua Feed, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AG Zoetis, Inc.
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Bayer AG
- AG Sanofi
- Ceva Sante Animale
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals
Highlights of The Non-Therapeutic Antibiotics for Food Animals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oxytetracyclines
- Tylosin
- Ampicillin and Amoxycillin
- Gentamicin
- Sulfaquinoxaline
- Salinomycin
- Bacitracin
- Others
- By Application:
- Cattle Feed
- Poultry Feed
- Swine Feed
- Aqua Feed
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Therapeutic Antibiotics for Food Animals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-therapeutic antibiotics are used to promote growth in food animals.
Some of the major companies in the non-therapeutic antibiotics for food animals market are AG Zoetis, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Bayer AG, AG Sanofi, Ceva Sante Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals.
The non-therapeutic antibiotics for food animals market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-Therapeutic Antibiotics for Food Animals Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-Therapeutic Antibiotics for Food Animals Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-Therapeutic Antibiotics for Food Animals Market - Supply Chain
4.5. Global Non-Therapeutic Antibiotics for Food Animals Market Forecast
4.5.1. Non-Therapeutic Antibiotics for Food Animals Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-Therapeutic Antibiotics for Food Animals Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-Therapeutic Antibiotics for Food Animals Market Absolute $ Opportunity
5. Global Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Type
5.3.1. Oxytetracyclines
5.3.2. Tylosin
5.3.3. Ampicillin and Amoxycillin
5.3.4. Gentamicin
5.3.5. Sulfaquinoxaline
5.3.6. Salinomycin
5.3.7. Bacitracin
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Application
6.3.1. Cattle Feed
6.3.2. Poultry Feed
6.3.3. Swine Feed
6.3.4. Aqua Feed
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-Therapeutic Antibiotics for Food Animals Demand Share Forecast, 2019-2029
9. North America Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Application
9.4.1. Cattle Feed
9.4.2. Poultry Feed
9.4.3. Swine Feed
9.4.4. Aqua Feed
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Type
9.7.1. Oxytetracyclines
9.7.2. Tylosin
9.7.3. Ampicillin and Amoxycillin
9.7.4. Gentamicin
9.7.5. Sulfaquinoxaline
9.7.6. Salinomycin
9.7.7. Bacitracin
9.7.8. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-Therapeutic Antibiotics for Food Animals Demand Share Forecast, 2019-2029
10. Latin America Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Application
10.4.1. Cattle Feed
10.4.2. Poultry Feed
10.4.3. Swine Feed
10.4.4. Aqua Feed
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Type
10.7.1. Oxytetracyclines
10.7.2. Tylosin
10.7.3. Ampicillin and Amoxycillin
10.7.4. Gentamicin
10.7.5. Sulfaquinoxaline
10.7.6. Salinomycin
10.7.7. Bacitracin
10.7.8. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-Therapeutic Antibiotics for Food Animals Demand Share Forecast, 2019-2029
11. Europe Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Application
11.4.1. Cattle Feed
11.4.2. Poultry Feed
11.4.3. Swine Feed
11.4.4. Aqua Feed
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Type
11.7.1. Oxytetracyclines
11.7.2. Tylosin
11.7.3. Ampicillin and Amoxycillin
11.7.4. Gentamicin
11.7.5. Sulfaquinoxaline
11.7.6. Salinomycin
11.7.7. Bacitracin
11.7.8. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-Therapeutic Antibiotics for Food Animals Demand Share, 2019-2029
12. Asia Pacific Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Application
12.4.1. Cattle Feed
12.4.2. Poultry Feed
12.4.3. Swine Feed
12.4.4. Aqua Feed
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Type
12.7.1. Oxytetracyclines
12.7.2. Tylosin
12.7.3. Ampicillin and Amoxycillin
12.7.4. Gentamicin
12.7.5. Sulfaquinoxaline
12.7.6. Salinomycin
12.7.7. Bacitracin
12.7.8. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-Therapeutic Antibiotics for Food Animals Demand Share, 2019-2029
13. Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Application
13.4.1. Cattle Feed
13.4.2. Poultry Feed
13.4.3. Swine Feed
13.4.4. Aqua Feed
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market Size and Volume Forecast by Type
13.7.1. Oxytetracyclines
13.7.2. Tylosin
13.7.3. Ampicillin and Amoxycillin
13.7.4. Gentamicin
13.7.5. Sulfaquinoxaline
13.7.6. Salinomycin
13.7.7. Bacitracin
13.7.8. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Non-Therapeutic Antibiotics for Food Animals Market: Market Share Analysis
14.2. Non-Therapeutic Antibiotics for Food Animals Distributors and Customers
14.3. Non-Therapeutic Antibiotics for Food Animals Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AG Zoetis, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer Ingelheim GmbH
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly and Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck & Co., Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AG Sanofi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Virbac
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vetoquinol S.A.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dechra Pharmaceuticals
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
